Detection of unintentional and intentional body signals to control device stimulation

Patent metadata

Field	Value
Publication number	US-2023256251-A1
Application number	US-202318104880-A
Country	US
Kind code	A1
Filing date	Feb 2, 2023
Priority date	Feb 2, 2022
Publication date	Aug 17, 2023
Grant date	—

Abstract

An implantable tibial nerve electrical stimulation therapy device, system and method configured to detect unintentional and intentional body signals to control and modify the electrical stimulation therapy, thereby enabling selective pausing of electrical stimulation therapy and increase/decrease in amplitude or frequency of the electrical stimulation therapy for improved safety, comfort and effective therapy.

First claim

What is claimed is:

1 . An implantable neurostimulation device, comprising:
circuitry for generating an electrical stimulation therapy; one or more electrodes configured to deliver the electrical stimulation therapy to a targeted nerve of a patient; and at least one sensor configured to sense data used by the circuitry to infer a distance between the one or more electrodes and the targeted nerve, wherein the circuitry is configured to modify the electrical stimulation therapy based on the inferred distance between the one or more electrodes in the targeted nerve.

2 . The implantable neurostimulation device of claim 1 , wherein the implantable neurostimulation device is adapted for tibial nerve stimulation.

3 . The implantable neurostimulation device of claim 2 , wherein the at least one sensor is configured to sense at least one of inversion, eversion, dorsiflexion, or plantar flexion in an ankle of the patient.

4 . The implantable neurostimulation system of claim 1 , wherein the implantable neurostimulation device is configured to at least one of selectively increase or decrease an amplitude of the electrical stimulation therapy based on the inferred distance between the one or more electrodes in the targeted nerve.

5 . The implantable neurostimulation system of claim 1 , wherein the amplitude of the electrical stimulation therapy is variable in a range of between about 0.1 mA and about 25 mA.

6 . The implantable neurostimulation device of claim 1 , wherein the one or more sensor is at least one of an accelerometer or electromyographic sensor.

7 . The implantable neurostimulation device of claim 1 , wherein the implantable neurostimulation device is configured to communicate with at least one of a mobile computing device, a desktop computer, smart watch, or a dedicated implantable neurostimulation device programmer.

8 . The implantable neurostimulation device of claim 1 , wherein the implantable neurostimulation device is configured to selectively pause the electrical stimulation therapy in response to a user defined tactile command.

9 . The implantable neurostimulation device of claim 1 , wherein the at least one sensor is further configured to sense data used by the circuitry to infer receipt of a user defined tactile command.

10 . The implantable neurostimulation device of claim 9 , wherein the implantable neurostimulation device is configured to at least one of pause the electrical stimulation therapy, skip an electrical stimulation therapy session, or change an amplitude of the electrical stimulation therapy in response to an inferred receipt of the user defined tactile command.

11 . The implantable neurostimulation device of claim 1 , wherein the at least one sensor is further configured to sense data used by the circuitry to infer operation of at least one of a vehicle or heavy machinery.

12 . The implantable neurostimulation device of claim 10 , wherein the implantable neural stimulation device is configured to selectively pause the electrical stimulation therapy in response to the inferred operation of at least one of a vehicle or heavy machinery.

13 . An implantable neurostimulation system, comprising:
an implantable neurostimulation device configured to deliver an electrical stimulation therapy to a targeted nerve of a patient via one or more electrodes; and an external sensor configured to sense patient activity inferring a change in distance between the one or more electrodes and the targeted nerve, wherein the implantable neurostimulation device is configured to modify the electrical stimulation therapy based on the inferred change in distance between the one or more electrodes in the targeted nerve.

14 . The implantable neurostimulation device of claim 13 , wherein the implantable neurostimulation device is adapted for tibial nerve stimulation.

15 . The implantable neurostimulation device of claim 13 , wherein the external sensor is at least one of a heart rate monitor, pulse oximeter, respiratory sensor, perspiration sensor, posture orientation sensor, motion sensor, accelerometer, or microphone.

16 . The implantable neurostimulation device of claim 13 , wherein the at least one signal correlates to patient operation of at least one of an automobile or heavy machinery.

17 . The implantable neurostimulation device of claim 16 , wherein the implantable neurostimulation device is configured to selectively pause the electrical stimulation therapy.

18 . An implantable neurostimulation system, comprising:
an implantable neurostimulation device configured to deliver an electrical stimulation therapy to a targeted nerve of a patient via one or more electrodes, the implantable neural stimulation device including at least one sensor configured to sense patient activity inferring a change in a distance between the one or more electrodes and the targeted nerve; and an external programmer configured to wirelessly communicate with the implantable neurostimulation device.

19 . The implantable neurostimulation system of claim 18 , wherein the at least one sensor is further configured to sense data used by the circuitry to infer receipt of a user defined tactile command.

20 . The implantable neurostimulation system of claim 19 , wherein the implantable neurostimulation device is configured to at least one of pause the electrical stimulation therapy, skip an electrical stimulation therapy session, or change an amplitude of the electrical stimulation therapy in response to an inferred receipt of the user defined tactile command.

Assignees

• Medtronic Inc

Inventors

• Offutt Sarah J
• Litvak Leonid M
• Shrivastav Maneesh

Classifications

• A61N1/37211

  Means for communicating with stimulators · CPC title

• A61N1/36007

  of urogenital or gastrointestinal organs, e.g. for incontinence control · CPC title

• A61N1/36139 Primary

  with automatic adjustment · CPC title

• A61N1/0551 Primary

  Spinal or peripheral nerve electrodes · CPC title